Professor Liz Sockett is a world authority on understanding and testing predatory bacteria as infection treatments, funded by BBSRC, Leverhulme and DARPA (with programme manager Dr Jess Tyson).

Liz has research collaborations with world leading experts on zebrafish models of infection, activity of bacterially predatory enzymes and clinically important emergent pathogens. She serves on UK and overseas grant panels (BBSRC, MRC Fellowships, DFG), strategic advisory boards (MRC’s MRF Studentships & Leaders Programmes) and strategic review panels (Max Planck Institute for Microbiology at Marburg Germany and Institute of Infection, Immunity & Inflammation Glasgow).

Liz and her research group study the predatory delta-Proteobacterium Bdellovibrio bacteriovorus. Bdellovibrio are tiny bacteria that naturally invade and eat the pathogenic bacteria that cause skin ulcer, pressure sore, gut, bladder and wound infections in people, whilst not being infectious themselves. Their long-term goals are to establish Bdellovibrio as a treatment for Gram-negative bacterial infections in humans, and in animals and plants.